Endovastec™ Wins "Pudong New Area Quality Gold Prize"

Shanghai, China – Shanghai MicroPort Endovascular MedTech Co., Ltd. ("Endovastec™") was recently awarded the "Pudong New Area Quality Gold Prize" ("the Prize") after a panel announced the results of the panel review and public inputs done for the third Pudong New Area Government Quality Prizes.

The third Pudong New Area Government Quality Prizes comprised the Head of Pudong New Area Quality Prize, the Prize and Quality Innovation Prize. The Prize is mainly awarded to the benchmark and model entities that show outstanding quality management achievements and leading economic and social contributions in Pudong New Area.

The selection for the third Pudong New Area Government Quality Prizes started in December 2018 and lasted almost a year. Endovastec™ beat the other companies and was awarded the Prize for its outstanding general operations and management ability as well as performance in the areas of innovation ability, quality management, social responsibility, and corporate culture.

Endovastec™ always adheres to giving top priority to quality and preference to profit, and has developed a comprehensive quality management model in which quality management measures and excellent performance management are integrated with corporate culture. Endovastec™ has built a high-quality team and achieved comprehensive increases in product quality, process quality, service quality and business quality. In July 2019, Endovastec™ was listed in the STAR Market of Shanghai Stock Exchange, becoming one of the few medical device companies in the first batch of companies listed in the STAR Market. In the future, Endovastec™ will continue to follow the "Qualtiy-led and Innovation-driven" development path to promote the development of independent brands with scientific and technological innovation. Endovastec™ will further elevate its ability of sustainable development to provide integrated therapeutic solutions of higher quality and efficiency for doctors and patients in the fields of endovascular and peripheral vascular diseases.